Secondary navigation: People section
1 / 2
0044 (0) 7773359364
Development Policy and Practice (DPP)
Faculty of Arts and Social Sciences
The Open University
Milton Keynes, MK7 6AA, UK
Andrew is an interdisciplinary researcher with a background in both business management and Computer science. His research interests focus on the development, innovation, governance and regulation of Medical Devices and their impact on health sector performance.
Andrew obtained a BSc (Hons) in Computer Science from London School of Management (2005) followed by an MBA from University of Bedfordshire (2007). He is also a recipient of an Honorary Testimonial inscribed on Parchment National Award from Royal Human Society (2013).
Before joining the Development Policy and Practice (DPP) at The Open University, as a PhD research student Andrew has worked as a Projects Consultant for World Delta, NHS Health advisor, Information Technology Lecturer for Nettex training Centre and as a Director for Macbooks Ltd in Milton Keynes, UK.
Current research (PhD)
Title: The Impact of Medical Equipment Regulatory Pathways (MERPs) on health system performance.
Dates: Jan 2015 â€“ Dec 2020
The aim of this project is to investigate the state of medical equipment, with respect to market, regulatory pathways and how this impact the performance of the health systems with special emphasis on the situation in the United Kingdom and South Africa but generally treating the UK as a specific example of European Community regulation.
The intended outcomes of this research will be: to offer useful academic, policy and practice recommendations on how the study countries (UK & SA) and the medical device sector globally can improve their regulatory systems currently in place so as to facilitate development and approval-for-use of effective devices while limiting access to unsafe or ineffective technology.
Proposals will be put forward for a rational medical equipment regulatory system, which could be applied worldwide, thus easing technical barriers to trade, simplifying the demands on medical device manufacturers and reducing the cost of meeting regulatory requirements.